CHPT
ChargePoint Holdings, Inc.
CHPT has the edge over F overall, supported by stronger fundamentals and stronger modeled upside.
F
Ford Motor Company
F has lower modeled downside risk, despite its lower overall score.
CHPT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
CHPT's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
CHPT PE Valuation
CHPT has no meaningful PE right now: it lost money over the past year.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
CHPT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
CHPT has the edge over F on the outlook, with more favorable revenue expectations.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CHPT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$7.26 | +$4.19 |
| Q2 2026 | -$8.76 | +$3.04 |
| Q1 2026 | -$9.41 | +$3.39 |
| Q4 2025 | -$10.08 | +$4.32 |
| Q3 2025 | -$11.45 | +$7.95 |
| Q2 2025 | -$11.80 | +$11.40 |
| Q1 2025 | -$12.80 | +$11.60 |
| Q4 2024 | -$14.40 | +$10.20 |
CHPT has the edge over F on earnings, with more consistent year-over-year improvement.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
CHPT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $116.1M | +18% |
| Q2 2026 | $101.8M | +4.3% |
| Q1 2026 | $109.3M | +7.3% |
| Q4 2025 | $105.7M | +6.1% |
| Q3 2025 | $98.6M | -9.2% |
| Q2 2025 | $97.6M | -8.8% |
| Q1 2025 | $101.9M | -12% |
| Q4 2024 | $99.6M | -9.7% |
CHPT's revenue is recovering but still below its 2023 peak: $116M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -29% | +31 points |
| Q2 2026 | -46% | +8.8 points |
| Q1 2026 | -48% | +5.5 points |
| Q4 2025 | -42% | +27 points |
| Q3 2025 | -60% | -2 points |
| Q2 2025 | -55% | +7.6 points |
| Q1 2025 | -54% | +26 points |
| Q4 2024 | -68% | +71 points |
CHPT's operating margin was −29% last quarter, up 30 points from the same quarter a year ago, near the top of its range since 2019.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F has the edge over CHPT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F has the edge over CHPT on profitability, with a higher operating margin.
CHPT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.2M | +$2.3M |
| Q2 2026 | -$37.7M | -$3.7M |
| Q1 2026 | -$2M | +$2.6M |
| Q4 2025 | -$23.6M | +$9.8M |
| Q3 2025 | -$7.5M | +$47.5M |
| Q2 2025 | -$34M | +$32M |
| Q1 2025 | -$4.6M | +$41.6M |
| Q4 2024 | -$33.4M | +$68.3M |
CHPT has burned cash in almost every quarter: −$68M over the past year, against −$79M the year before.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F has the edge over CHPT on cash generation, producing positive trailing cash flow while its opponent burns cash.
CHPT Net Leverage
CHPT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has more cash than debt.
CHPT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.1 | Neutral |
| Stochastic | 84.4 | Overbought |
CHPT's weekly RSI is 65 (neutral) and its Stochastic is 84 (overbought).
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
CHPT PE vs Consumer Cyclical Sector
CHPT has no meaningful PE right now: it lost money over the past year.
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
CHPT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.32 | 29% above |
| 20 week MA | $7.81 | 54% above |
| 50 week MA | $7.08 | 70% above |
| 100 week MA | $10.4 | 16% above |
| 200 week MA | $49.3 | 76% below |
CHPT has the edge over F on trend strength, trading above more of its moving averages.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
CHPT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $196.0 | $922.0 | +370% |
| 2021 | $922.0 | $381.0 | -59% |
| 2022 | $381.0 | $171.0 | -55% |
| 2023 | $171.0 | $46.8 | -73% |
| 2024 | $46.8 | $22.8 | -51% |
| 2025 | $22.8 | $7.08 | -69% |
| 2026 YTD | $7.08 | $12.1 | +70% |
CHPT has the edge over F on returns for 2026, with the stronger performance.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F's yearly returns have swung widely, from +129% in 2021 to −44% in 2022. It's down 11% so far in 2026.